Abstract Submission Deadline  December 15, 2009

Preparation of Abstract:  We recommend that you use Microsoft Word to prepare your final abstract.  You may then cut and paste it into the main body of the abstract box.

Brochure Website  www.cme.med.miami.edu

QUICK LINKS
Abstract Submission
Submission Instructions
Poster Information

Substitute Submission Instructions

We recommend that you use Microsoft Word to prepare your final abstract.  You may then cut and paste it into the main body of the abstract box.

Abstract submissions are eligible if they have not been published prior to December 2009. Submissions may have been presented previously at other meetings.

Main body of abstract (no more than 400 words)

  • No figures or graphs, but simple tables are acceptable
  • Use of standard abbreviations is acceptable; place unusual abbreviations in parentheses after first use of the full term
  • For a text-only abstracts, no more than 400 words maximum in the body of the abstract
  • For abstracts that include a table, no more than 300 words maximum in the body of the abstract (abstract + 1 table)

Abstract Selection:  Abstracts will be blinded and reviewed by a panel of judges.  Each category of the competition (research, innovations, and clinical vignettes) will be judged separately. The most worthy abstracts will be selected for poster presentation at the Perioperative Medicine Summit 2010. The selection process will be the same regardless of the method of presentation.  Instructions for posters will be provided upon notification of selection. Posters will be judged during the Reception/Poster Session on Thursday evening, March 4, 2010 from 5:30-7:00 p.m. Judges will also select up to three abstracts for oral presentation at a plenary session on Friday, March 5, 2010, at 12:45 p.m.

Notification of Results: All primary authors will be notified via email of the initial judging by January 11, 2010.  Awards will be given at the Perioperative Medicine Summit 2010 to the best abstract(s) in each category. Judges will consider not only the quality of the initial abstract submission, but also the quality of the poster and presenting author’s discussion of their work during the poster session.

Presenting Author’s Availability:  The presenting author (preferably the primary author) must be available to present his or her work at the Perioperative Medicine Summit 2010 on March 4th and March 5th, 2010 in Miami Beach, FL.  Authors will be responsible for any associated costs including travel, meeting registration, and poster preparation.

Publication of Abstracts: Abstracts will be published in handbook which will be available at the time of the meeting.

Disclosure Statement Regarding Conflict of Interest
SPAQI and the University of Miami Miller School of Medicine promote improved quality in patient care, teaching and research.  All authors submitting abstracts to the Research, Innovations and Clinical Vignette Competition are required to disclose any relationships with pharmaceutical companies, biomedical device manufacturers or other organizations that could represent potential conflicts in their presentation. The submitting author is responsible for providing disclosure information for all co-authors. This requirement applies to currently existing relationships or relationships within the past year that relate to the abstract entry.  The principal intent of this disclosure is not to prevent authors with a potential conflict from submitting an abstract or presenting their work. Disclosure information will assist the abstract committee members in the review process. Conference participants will also be provided with disclosure information in the program abstract book so that they may form their own judgments about potential conflicts of interest in relationship to the abstracts/presentations.

Style: Write for clarity and directness. It is NOT acceptable to state, “The results will be discussed.” Avoid the use of medical jargon or stock empty phrases.

Informed Consent: If in the conduct of these studies, human or animal species were exposed to risks not required by their medical needs, the author affirms that the study was approved by an appropriate committee, or if no such committee was available and informed consent was needed, it was obtained in accordance with the principles set forth in “The Institutional Guide to DHEW Policy on Protection of Human Subjects” and the “Guide for the Care and Use of Laboratory Animals,” published by the NIH.

Abbreviations, Symbols, and Nomenclature: Usage should conform as closely as possible to that recommended in the CBE Style Manual (6th edition, 1994), published by the Council of Biology Editors and available from CBE Secretariat, 9650 Rockville Pike, Bethesda, MD, 20814. Nonstandard abbreviations must be kept to a minimum and must be explained when used. Generic names of drugs are preferred: a propriety name may be given only with the first use of the generic name.

Units of Measurement: Metric (SI), including those for height, length, mass (weight), and body temperature. Measurements for substances of known, pure composition should be in millimoles/milliliter or millimoles/liter; for mixtures of substances where exact composition is not known, use grams/liter.

SELECT YOUR SUBMISSION CATEGORY:

Research in Perioperative Care
Innovations in Perioperative Medicine
Perioperative Clinical Vignettes